Atle Fund Management AB as of June 30, 2026
Portfolio Holdings for Atle Fund Management AB
Atle Fund Management AB holds 39 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 9.6 | $36M | 30k | 1199.43 | |
| Merck & Co (MRK) | 6.5 | $24M | 189k | 128.50 | |
| Johnson & Johnson (JNJ) | 5.8 | $22M | 85k | 253.97 | |
| Abbvie (ABBV) | 4.4 | $16M | 64k | 251.64 | |
| CVS Caremark Corporation (CVS) | 4.1 | $15M | 146k | 103.45 | |
| Thermo Fisher Scientific (TMO) | 3.8 | $14M | 28k | 501.36 | |
| Revolution Medicines (RVMD) | 3.7 | $14M | 73k | 187.28 | |
| Biogen Idec (BIIB) | 3.6 | $14M | 63k | 216.06 | |
| Neurocrine Biosciences (NBIX) | 3.3 | $12M | 73k | 168.53 | |
| Mirum Pharmaceuticals (MIRM) | 3.2 | $12M | 101k | 117.07 | |
| Alkermes SHS (ALKS) | 3.0 | $11M | 213k | 52.40 | |
| Ionis Pharmaceuticals (IONS) | 2.9 | $11M | 137k | 79.29 | |
| Beone Medicines Ltd- Sponsored Ads (ONC) | 2.7 | $10M | 35k | 284.97 | |
| Intuitive Surgical Com New (ISRG) | 2.6 | $9.8M | 25k | 397.68 | |
| Stryker Corporation (SYK) | 2.6 | $9.5M | 30k | 314.84 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.6 | $9.5M | 19k | 496.73 | |
| Edwards Lifesciences (EW) | 2.5 | $9.3M | 103k | 90.46 | |
| Bridgebio Pharma (BBIO) | 2.5 | $9.3M | 125k | 74.48 | |
| Krystal Biotech (KRYS) | 2.4 | $8.9M | 24k | 371.67 | |
| AmerisourceBergen (COR) | 2.4 | $8.8M | 31k | 282.98 | |
| Newamsterdam Pharma Co Nv Ordinary Shares (NAMS) | 2.3 | $8.4M | 249k | 33.89 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.1 | $7.8M | 58k | 133.26 | |
| Incyte Corporation (INCY) | 1.7 | $6.5M | 57k | 113.36 | |
| Irhythm Technologies (IRTC) | 1.7 | $6.4M | 54k | 118.95 | |
| Boston Scientific Corporation (BSX) | 1.7 | $6.2M | 146k | 42.68 | |
| Insmed Com Par $.01 (INSM) | 1.7 | $6.2M | 58k | 106.62 | |
| Tango Therapeutics (TNGX) | 1.7 | $6.2M | 199k | 31.26 | |
| Gilead Sciences (GILD) | 1.6 | $5.8M | 46k | 126.34 | |
| Cardinal Health (CAH) | 1.5 | $5.6M | 24k | 237.56 | |
| Oruka Therapeutics (ORKA) | 1.4 | $5.2M | 55k | 95.17 | |
| Spyre Therapeutics Com New (SYRE) | 1.4 | $5.1M | 57k | 88.78 | |
| Dexcom Com New (DXCM) | 1.3 | $4.8M | 72k | 67.35 | |
| Bicara Therapeutics (BCAX) | 1.2 | $4.3M | 146k | 29.69 | |
| Ideaya Biosciences (IDYA) | 0.9 | $3.5M | 95k | 37.27 | |
| Celcuity (CELC) | 0.9 | $3.5M | 33k | 104.62 | |
| Disc Medicine (IRON) | 0.9 | $3.2M | 44k | 73.14 | |
| Pyxis Oncology Common Stock (PYXS) | 0.8 | $2.9M | 967k | 3.01 | |
| Compass Therapeutics (CMPX) | 0.6 | $2.3M | 1.0M | 2.19 | |
| Jade Biosciences Com New (JBIO) | 0.5 | $2.0M | 89k | 22.22 |
